|
Thu, 04/10/2025 - 19:11 |
New key genes in Parkinsons disease identified using CRISPR technology |
Northwestern Un... |
|
Thu, 04/10/2025 - 07:45 |
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting |
Alterity Therap... |
|
Tue, 04/08/2025 - 00:23 |
A labor of love: UNT researcher uses personal journey to tackle Parkinsons Disease |
University of N... |
|
Tue, 04/01/2025 - 01:23 |
UCB presents key data from Alzheimers and Parkinsons disease research programs at AD/PD 2025 |
UCB |
|
Wed, 03/26/2025 - 23:33 |
Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy |
Alterity Therap... |
|
Tue, 03/11/2025 - 17:52 |
AMERICAN PARKINSON DISEASE ASSOCIATION TO EDUCATE AND EMPOWER DURING PARKINSONS DISEASE AWARENESS MONTH |
APDA |
|
Fri, 02/21/2025 - 11:16 |
2025 Winter Neurodegeneration Summit: Whats on the horizon in neurodegeneration research? |
Van Andel |
|
Wed, 01/15/2025 - 12:34 |
New Breakthrough Consortium for Olfactory Health offers Hope for the Many People Living with Smell Disorders |
Monell |
|
Tue, 12/17/2024 - 01:45 |
Findings from minzasolmin proof-of-concept ORCHESTRA study shape next steps in UCB Parkinsons research program |
UCB |
|
Sun, 08/25/2024 - 09:50 |
Low-dose carbon monoxide may explain the paradoxical reduced risk of Parkinsons disease among smokers |
Massachusetts G... |
|
Tue, 08/20/2024 - 18:57 |
Self-adjusting brain pacemaker may help reduce Parkinsons disease symptoms |
NIH |
|
Sat, 08/17/2024 - 08:21 |
LDH issues 'do not use' water advisory for area served by Walnut Bayou Water System in Madison Parish |
Louisiana Depar... |
|
Thu, 08/08/2024 - 16:25 |
Rice lab pioneers noninvasive measurement of gene expression at target locations in the brain |
RiceUniv |
|
Thu, 08/08/2024 - 16:16 |
Faster in a dish model may speed up treatment for Parkinsons |
Harvard |
|
Tue, 06/18/2024 - 15:09 |
Diagnosing essential tremor after death helps families learn risk |
UTSouthwestern |
|
Mon, 06/17/2024 - 12:04 |
Inhibikase Therapeutics Completes Enrollment of the Phase 2 201 Trial Evaluating Risvodetinib in Untreated Parkinsons Disease |
Inhibikase Ther... |
|
Sat, 05/25/2024 - 00:49 |
The Michael J. Fox Foundation Applauds Passage of National Plan to End Parkinsons Act in Congress |
The Michael J. ... |
|
Sun, 05/19/2024 - 23:24 |
Northwestern Medicine Parkinsons patients take the stage for their first-ever public performance at The Joffrey Ballet |
Northwestern Me... |
|
Wed, 05/15/2024 - 11:13 |
Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement |
Inhibikase Ther... |
|
Fri, 02/23/2024 - 12:46 |
Cure Parkinsons and Van Andel Institute fund Phase 2 clinical trial of dapansutrile for Parkinsons |
Van Andel |
|
Thu, 02/01/2024 - 13:32 |
Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib |
Inhibikase Ther... |
|
Fri, 01/19/2024 - 13:52 |
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli |
Inhibikase Ther... |
|
Mon, 12/26/2022 - 23:02 |
New technique improves high-intensity focused ultrasound treatment for brain disorders |
UTSouthwestern |
|
Tue, 11/22/2022 - 08:57 |
Inhibikase Therapeutics to Present at Piper Sandler 34th Annual Healthcare Conference |
Inhibikase Ther... |
|
Fri, 11/04/2022 - 12:40 |
California Regulators Urged to Ban Herbicide Linked to Parkinsons Disease |
Center for Biol... |
